For: | Kawakami E, Machado RS, Ogata SK, Langner M, Fukushima E, Carelli AP, Bonucci VCG, Patrício FRS. Furazolidone-based triple therapy for H pylori gastritis in children. World J Gastroenterol 2006; 12(34): 5544-5549 [PMID: 17006997 DOI: 10.3748/wjg.v12.i34.5544] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i34/5544.htm |
Number | Citing Articles |
1 |
Rodrigo Strehl Machado, Marialice Reber, Francy Reis da Silva Patrício, Elisabete Kawakami. Gastric Emptying of Solids Is Slower in Functional Dyspepsia Unrelated to Helicobacter pylori Infection in Female Children and Teenagers. Journal of Pediatric Gastroenterology and Nutrition 2008; 46(4): 403 doi: 10.1097/MPG.0b013e318159224e
|
2 |
C. Chiesa, L. Pacifico, C. Anania, E. Poggiogalle, F. Chiarelli, J.F. Osborn. Helicobacter Pylori Therapy in Children: Overview and Challenges. International Journal of Immunopathology and Pharmacology 2010; 23(2): 405 doi: 10.1177/039463201002300203
|
3 |
Mitsushige Sugimoto, Takahisa Furuta, Naohito Shirai, Chise Kodaira, Masafumi Nishino, Mihoko Yamade, Mutsuhiro Ikuma, Hiroshi Watanabe, Kyoichi Ohashi, Akira Hishida, Takashi Ishizaki. Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics. Expert Opinion on Pharmacotherapy 2007; 8(16): 2701 doi: 10.1517/14656566.8.16.2701
|
4 |
Silvio K. Ogata, Anita P. Ortiz Godoy, Francy R. da Silva Patricio, Elisabete Kawakami. High Helicobacter pylori Resistance to Metronidazole and Clarithromycin in Brazilian Children and Adolescents. Journal of Pediatric Gastroenterology and Nutrition 2013; 56(6): 645 doi: 10.1097/MPG.0b013e31828b3669
|
5 |
M. Sugimoto, S. Sahara, H. Ichikawa, T. Kagami, T. Uotani, T. Furuta. High Helicobacter pylori cure rate with sitafloxacin‐based triple therapy. Alimentary Pharmacology & Therapeutics 2015; 42(4): 477 doi: 10.1111/apt.13280
|
6 |
HB Pandya, Harihar Har Agravat, JS Patel, NRK Sodagar. Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat. Indian Journal of Medical Microbiology 2014; 32(4): 408 doi: 10.4103/0255-0857.142256
|
7 |
Mitsushige Sugimoto, Takahiro Uotani, Shu Sahara, Hitomi Ichikawa, Mihoko Yamade, Ken Sugimoto, Takahisa Furuta. Efficacy of Tailored Helicobacter pylori Eradication Treatment Based on Clarithromycin Susceptibility and Maintenance of Acid Secretion. Helicobacter 2014; 19(4): 312 doi: 10.1111/hel.12128
|
8 |
Gabor Veres, Ender Pehlivanoglu. Helicobacter pylori Infection in Pediatrics. Helicobacter 2007; 12(s1): 38 doi: 10.1111/j.1523-5378.2007.00532.x
|
9 |
Harohalli Shashidhar, Deborah Flomenhoft, Vasundhara Tolia. Helicobacter pylori& beyond: pediatric peptic ulcer disease. Therapy 2009; 6(1): 65 doi: 10.2217/14750708.6.1.65
|
10 |
Mitsushige Sugimoto, Yoshio Yamaoka. Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy. Archivum Immunologiae et Therapiae Experimentalis 2009; 57(1): 45 doi: 10.1007/s00005-009-0007-z
|
11 |
Mitsushige Sugimoto, Hideo Yasuda, Akira Andoh. Nutrition status and <i>Helicobacter pylori</i> infection in patients receiving hemodialysis. World Journal of Gastroenterology 2018; 24(15): 1591-1600 doi: 10.3748/wjg.v24.i15.1591
|
12 |
Mitsushige Sugimoto, Takahisa Furuta, Naohito Shirai, Chise Kodaira, Masafumi Nishino, Mutsuhiro Ikuma, Takashi Ishizaki, Akira Hishida. Evidence that the Degree and Duration of Acid Suppression are Related to Helicobacter pylori Eradication by Triple Therapy. Helicobacter 2007; 12(4): 317 doi: 10.1111/j.1523-5378.2007.00508.x
|
13 |
Camila Cabrera, Joaquín Torres, Carolina A. Serrano, Paulina Gallardo, Vicente Orellana, Sergio George, Miguel O'Ryan, Yalda Lucero. Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008–2023): A Systematic Review. Helicobacter 2024; 29(4) doi: 10.1111/hel.13101
|
14 |
Shu Sahara, Mitsushige Sugimoto, Masaki Murata, Eri Iwata, Takashi Kawai, Kazunari Murakami, Yoshio Yamaoka, Tadashi Shimoyama. Eradication Therapy for Helicobacter pylori Infection in Patients Receiving Hemodialysis: Review. Helicobacter 2024; 29(3) doi: 10.1111/hel.13106
|
15 |
Luiz Gonzaga Coelho, Ismael Maguinilk, Schlioma Zaterka, José Miguel Parente, Maria do Carmo Friche Passos, Joaquim Prado P. Moraes-Filho. 3rd BRAZILIAN CONSENSUS ON Helicobacter pylori. Arquivos de Gastroenterologia 2013; 50(2): 81 doi: 10.1590/S0004-28032013005000001
|
16 |
Suelen Bianca S. Martins, Maria Ângela B. Brandão, Marcelo Barciela Brandão, Marcelo Conrado dos Reis, Maria de Fátima C. P. Servidone, Mariana Porto Zambon. Diagnóstico pouco frequente de dor abdominal em unidade de emergência infantil. Revista Paulista de Pediatria 2010; 28(2): 249 doi: 10.1590/S0103-05822010000200019
|
17 |
Mitsushige Sugimoto, Shu Sahara, Hitomi Ichikawa, Takuma Kagami, Hiromitsu Ban, Taketo Otsuka, Akira Andoh, Takahisa Furuta. Four‐times‐daily Dosing of Rabeprazole with Sitafloxacin, High‐Dose Amoxicillin, or Both for Metronidazole‐Resistant Infection with Helicobacter pylori in Japan. Helicobacter 2017; 22(1) doi: 10.1111/hel.12319
|